Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
bristol-myers squibb
cancer
life sciences
national
4
×
national blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
esmo
european society for medical oncology
immunotherapy
indiana blog main
indiana top stories
keytruda
merck
mirati therapeutics
national top stories
new york blog main
new york top stories
novartis
opdivo
parp
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
samit hirawat
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
What
clinical
4
×
medical
4
×
acquisition
anniversary
annual
approaches
bn
bristol
cancer
celgene
chief
company’s
conference
corporation
diversity
esmo
european
hirawat
myers
myers’s
officer
oncology
pipeline
progress
scrip
society
spoke
squibb
trial
year
ash
barcelona
breast
cancer's
data
december's
kras
lines
lung
major
Language
unset
Current search:
national
×
medical
×
clinical
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front